Yang, Huiqin; Craig, Dawn; Epstein, David; Bojke, Laura; … - In: PharmacoEconomics 30 (2012) 4, pp. 257-270
The National Institute for Health and Clinical Excellence (NICE) invited the manufacturer of golimumab (Schering-Plough/Centocor) to submit evidence for the clinical and cost effectiveness of this drug for the treatment of active and progressive psoriatic arthritis (PsA) in patients who have...
